Influence of hydralazine administration on oxygenation in spontaneous and transplanted tumor models

International Journal of Radiation Oncology Biology Physics

Volumn 49, Issue 3, 2001, Pages 799-808

  Fenton, Bruce M ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Blood vessels; Hypoxic marker; Mammary tumors; Perfusion; Vasculature

Indexed keywords

HYDRALAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CANCER MODEL; DRUG EFFECT; FEMALE; FIBROSARCOMA; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE OXYGENATION; TISSUE PERFUSION; TISSUE PRESSURE; TUMOR BLOOD FLOW;

ANIMALS; CARBOCYANINES; CELL HYPOXIA; ETANIDAZOLE; FEMALE; FIBROSARCOMA; FLUORESCENT DYES; HYDRALAZINE; HYDROCARBONS, FLUORINATED; INDICATORS AND REAGENTS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEOPLASMS; OXYGEN; RADIOBIOLOGY; TUMOR CELLS, CULTURED; VASODILATOR AGENTS;

EID: 0035283729     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)01400-0     Document Type: Article

References (29)

1. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo
2. Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine
3. Chemical modification of tumour blood flow
4. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSaII tumors
5. Effects of two tumor blood flow modifiers, hydralazine and flavone acetic acid, on KHT tumours and normal tissues in mice
6. The response of spontaneous and transplantable murine tumors to vasoactive agents measured by 31P magnetic resonance spectroscopy
7. Are transplanted tumours suitable as models for studies on vasculature?
8. Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours
9. Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and P-31-magnetic resonance spectroscopy
10. Characterization of the vasculature within a murine adenocarcinoma growing in different sites to evaluate the potential of vascular therapies
11. Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid
12. Endostatin. An endogenous inhibitor of angiogenesis and tumor growth
13. 2 saturation measurements
14. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts
15. Use of a carbocyanine dye as a marker of functional vasculature in murine tumours
16. Vascular morphometry of KHT and RIF-1 murine sarcomas
17. Tamoxifen induces hypoxia in MCF-7 xenografts
18. Reduction in tumour blood flow in skin flap tumour after hydralazine is not due to a vascular steal phenomenon
19. Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure
20. The use of hydralazine to manipulate tumour temperatures during hyperthermia
21. Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors; Clinical implications
22. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors; implications for vascular collapse
23. Comparative effects of hydralazine on perfusion of KHT tumor, kidney and liver and on renal function in mice
24. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts; Acute and chronic hypoxia in individual tumours
25. Inducible repair and the two forms of tumour hypoxia - Time for a paradigm shift
26. Interstitial fluid pressure in intracranial tumours in patients and in rodents
27. Lack of general correlation between interstitial fluid pressure and oxygen partial pressure in solid tumors
28. Interstitial hypertension in head and neck tumors in patients; Correlation with tumor size